Deciphering in vivo metabolic profile and pharmacological mechanisms of Jitongning Tablet for the treatment of Ankylosing spondylitis

• Published in: Journal of pharmaceutical and biomedical analysis 2023-04, Vol.227, p.115271-115271, Article 115271
• Main Authors: Tian, Danmei, Zhao, Huadong, Cao, Jing, Zhang, Sihao, Wang, Wanqi, Tang, Xiyang, Dai, Yi, Zhou, Wangyi, Zhang, Lihua, Tian, Jiefeng, Han, Yuanyuan, Tang, Jinshan, Song, Zhaohui, Ma, Xiaohui, He, Yi, Yao, Xinsheng
• Format: Article
• Language: English
• Subjects: Analgesic effect; Analgesics - therapeutic use; Animals; Ankylosing spondylitis; Anti-inflammatory effect; Arthritis, Experimental - chemically induced; Arthritis, Experimental - drug therapy; Arthritis, Experimental - pathology; Drugs, Chinese Herbal - adverse effects; Inflammation - drug therapy; Jitongning Tablet (JTNT); Mice; Molecular docking; Molecular Docking Simulation; Network pharmacology; Rats; Spondylitis, Ankylosing - drug therapy; Tablets - adverse effects
• ISSN: 0731-7085; 1873-264X
• DOI: 10.1016/j.jpba.2023.115271

Jitongning tablet (JTNT) is a Traditional Chinese Medicine (TCM) prescription used for the treatment of Ankylosing spondylitis (AS). Currently, it is in phase II clinical trial (NCT03932019) for patients with active axial Spondyloarthritis (axSpA), showing great promise for the treatment of AS. However, the potential material basis and the underlying mechanisms for JTNT to treat AS remain elusive. Here, we performed UPLC-Q-TOF-MS to determine the in vivo metabolic profile of JTNT in rats and conducted in vivo studies including acetic acid-induced writhing, hot plate models, and collagen-induced arthritis (CIA) in rats to evaluate and validate the analgesic and anti-inflammatory effects of JTNT, two main symptoms for AS. Additionally, network pharmacology combined with molecular docking was performed to investigate the potential underlying mechanisms. As a result, a total of 116 xenobiotics were identified from the plasma, urine, and brain tissues of rats after oral administration of JTN extracts. Pharmacological evaluation revealed that fractions JTN-3 and JTN-4 exerted significant analgesic activities by reducing the number of writhes in an acetic acid-induced writhing mice model. JTN extract also exerted excellent therapeutic effects in the CIA model by ameliorating paw edema and decreasing systemic manifestation of inflammation and the level of circulating immune complex (CIC) and interferon γ (IFN-γ). Fractions of JTN extract, especially JTN-2 and JTN-4, on the other hand, ameliorated the secondary lesions caused by chicken type II collagen (CII) to a certain extent. Further, network pharmacology combined with molecular docking suggested crucial roles of inflammation and immune-related genes such as MAPK1, MAPK14, NOS3, and RELA in the treatment of AS by JTNT. In conclusion, our studies suggest that the isoquinoline and diterpenoid alkaloids from Corydalis Rhizoma and Aconiti Radix Cocta, along with coumarins from Angelicae Pubescentis Radix, may be the main bioactive components, and the AS treatment mechanism may mainly involve immune regulation of JTNT. These results help clarify the potential material basis and underlying mechanisms of JTNT for the treatment of AS, facilitating the broad application of this TCM in clinical practice. [Display omitted] •116 xenobiotics were identified based on the in vivo metabolic study of JTNT.•Analgesic effect was evaluated by acetic acid-induced writhing and hot plate models.•Anti-inflammatory effect was evaluated